Enter assignee name

CIPO Patents = 4

EPO Patents = 2

Forward Citations = 2

Loading Chart...

8 inventors (with patents filed for the assignee):

Hai Yan (9 out of 36 patents)

Frank J Calzone (6 out of 22 patents)

John Zhang (4 out of 4 patents)

4. Jim Shi (3 out of 3 patents)

5. Jeong Oh (1 out of 1 patent)

11 patents: Sort by Forward Citations

1. 11629184 - Calcitonin gene-related peptide (CGRP) antagonist antibodies (2023-04-18),

2. 11447555 - Methods for treating type 1 diabetes using glucagon receptor antagonistic antibodies (2022-09-20),

3. 11446376 - Methods for treating heart failure using glucagon receptor antagonistic antibodies (2022-09-20),

4. 11332531 - Immunotherapy using antibodies that bind programmed death ligand-1 (PD-L1) (2022-05-17),

5. 11319376 - Combination of glucagon receptor antagonists and PI3K pathway inhibitors for the treatment of cancer (2022-05-03),

6. 11319372 - Cancer treatment using antibodies that bind cytotoxic T-lymphocyte antigen-4 (CTLA-4) (2022-05-03),

7. 11248049 - Immunotherapy using antibodies that bind Programmed Death 1 (PD-1) (2022-02-15),

8. 11242398 - Anti-OX40 antibodies and methods of activating OX40 (2022-02-08),

9. 10765737 - Methods for treating heart failure using glucagon receptor antagonistic antibodies (2020-09-08),

10. 10752693 - Methods for treating obesity and nonalcoholic fatty liver disease or nonalcoholic steatohepatitis using glucagon receptor antagonistic antibodies (2020-08-25),

11. 10626179 - Methods for treating type 1 diabetes using glucagon receptor antagonistic antibodies (2020-04-21),

REMD Biotherapeutics, Inc. is a biotechnology company specialized in developing advanced therapeutics for various diseases. With a focus on innovative research and cutting-edge technologies, REMD aims to revolutionize the field of biopharmaceuticals. Through extensive scientific expertise and collaboration with leading academic institutions, REMD is committed to delivering groundbreaking solutions for unmet medical needs. With a strong dedication to improving patient outcomes, REMD strives to make a significant impact in the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

11 Patents

#28 in Camarillo, CA

#6,325 in California

#26,680 in US

#50,159 in the World

Camarillo, CA, United States of America

Remd Biotherapeutics, Inc.